Podcasts about type 2 diabetes research

Welcome to this episode of The Tonic, terrestrially broadcast on October 30 and 31, 2021 on AM740 and FM 96.7 in Toronto. Topics covered on the show track the lifestyle articles and themes published in Tonic Magazine. This week we discuss how Covid-19 has impacted Canadian's eye health with Laura Feltz and Doug Earle, the characteristics of sexually healthy adults with Carlyle Jansen, type 2 Diabetes research and weight loss with Dr. Thomas Ransom and the connection between instincts and motivation with Stacy Irvine.

http://www.einstein.yu.edu - Jeffrey Pessin, Ph.D., discusses basic and clinical diabetes research being conducted at Einstein and Montefiore Medical Center, including the brain’s influence on appetite, autoimmune and stem cell therapies, and the efforts to develop an artificial pancreas. Dr. Pessin is director of Einstein’s Diabetes Research Center. This edition of Einstein On is hosted by Gordon Earle, associate dean for communications and public affairs.

November 2, 2009 — Sustaining modest weight loss for 10 years, or taking an anti-diabetic drug over that time, can prevent or lower the incidence of type 2 diabetes in people at high risk for developing the disease, according to the Diabetes Prevention Program Outcomes Study (DPPOS), a long-term follow-up to a landmark 2001 diabetes prevention study.

July 22, 2009 — A cellular protein that may prevent nerve cells from dying also helps to improve insulin action and lower blood glucose levels, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University in collaboration with scientists at University of California, Los Angeles (UCLA).

During a panel discussion on diabetes and stem cell therapy, Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, discusses type 1 and type 2 diabetes in detail and the potential role of stem cell therapy. The event was organized by the New York Stem Cell Foundation. (April 29, 2009).